よむ、つかう、まなぶ。
10参考資料２ 令和6年度総括報告書「同種造血幹細胞移植患者に対する優先度の高い公的予防接種の再接種に関する研究」 (16 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_73851.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第34回 6／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
https://doi.org:10.1016/s0022-3476(96)70280
22
acyclovir against varicella-zoster virus
Tomonari, A. et al. Varicella-zoster virus
reactivation after allogeneic hematopoietic stem
infection in adult patients after unrelated cord
cell transplantation. American journal of
blood transplantation: a single institute
hematology 83, 472-476 (2008).
experience in Japan. British journal of
https://doi.org:10.1002/ajh.21152
29
long-term ultra-low-dose acyclovir for varicella
96.x
zoster virus disease after allogeneic
Vandenbosch, K. et al. Varicella-zoster virus
hematopoietic stem cell transplantation.
disease is more frequent after cord blood than
International journal of infectious diseases :
IJID : official publication of the International
Society for Infectious Diseases 19, 26-32 (2014).
blood and marrow transplantation : journal of the
American Society for Blood and Marrow
Transplantation 14, 867-871 (2008).
Seo, S. et al. Human rhinovirus detection in the
Kanda, Y. et al. Long-term low-dose acyclovir
transplant recipients: association with mortality.
against varicella-zoster virus reactivation after
Haematologica 102, 1120-1130 (2017).
allogeneic hematopoietic stem cell
https://doi.org:10.3324/haematol.2016.153767
31
Wada-Shimosato, Y. et al. Effectiveness of
689-692 (2001).
acyclovir prophylaxis against varicella zoster
https://doi.org:10.1038/sj.bmt.1703214
virus disease after allogeneic hematopoietic cell
Thomson, K. J. et al. The effect of low-dose
transplantation: A systematic review and
aciclovir on reactivation of varicella zoster virus
meta-analysis. Transplant infectious disease : an
after allogeneic haemopoietic stem cell
official journal of the Transplantation Society 21,
transplantation. Bone marrow transplantation 35,
e13061 (2019).
1065-1069 (2005).
https://doi.org:10.1111/tid.13061
32
渡辺大輔. 新規帯状疱疹サブユニットワクチン.
IASR 39, 142-144 (2018).
Boeckh, M., Kim, H. W., Flowers, M. E.,
Meyers, J. D. & Bowden, R. A. Long-term
33
Sauerbrei, A., Prager, J., Hengst, U., Zintl, F. &
acyclovir for prevention of varicella zoster virus
Wutzler, P. Varicella vaccination in children
disease after allogeneic hematopoietic cell
after bone marrow transplantation. Bone marrow
transplantation--a randomized double-blind
transplantation 20, 381-383 (1997).
placebo-controlled study. Blood 107,
https://doi.org:10.1038/sj.bmt.1700909
1800-1805 (2006).
27
30
lower respiratory tract of hematopoietic cell
https://doi.org:10.1038/sj.bmt.1704959
26
https://doi.org:10.1016/j.ijid.2013.09.020
https://doi.org:10.1016/j.bbmt.2008.05.006
transplantation. Bone marrow transplantation 28,
25
Kawamura, K. et al. Prophylactic role of
https://doi.org:10.1046/j.1365-2141.2003.044
after bone marrow transplantation. Biology of
24
Asano-Mori, Y. et al. Long-term ultra-low-dose
-9
haematology 122, 802-805 (2003).
23
28
34
Chun, J. Y. et al. Immunogenicity and safety of a
https://doi.org:10.1182/blood-2005-09-3624
live herpes zoster vaccine in hematopoietic stem
Erard, V. et al. One-year acyclovir prophylaxis
cell transplant recipients. BMC infectious
for preventing varicella-zoster virus disease
diseases 21, 117 (2021).
after hematopoietic cell transplantation: no
https://doi.org:10.1186/s12879-021-05806-4
evidence of rebound varicella-zoster virus
35
Kamboj M, Bohlke K, Baptiste DM, Dunleavy
disease after drug discontinuation. Blood 110,
K, Fueger A, Jones L et al. Vaccination of
3071-3077 (2007).
Adults With Cancer: ASCO Guideline. J Clin
https://doi.org:10.1182/blood-2007-03-07764
4
16
22
acyclovir against varicella-zoster virus
Tomonari, A. et al. Varicella-zoster virus
reactivation after allogeneic hematopoietic stem
infection in adult patients after unrelated cord
cell transplantation. American journal of
blood transplantation: a single institute
hematology 83, 472-476 (2008).
experience in Japan. British journal of
https://doi.org:10.1002/ajh.21152
29
long-term ultra-low-dose acyclovir for varicella
96.x
zoster virus disease after allogeneic
Vandenbosch, K. et al. Varicella-zoster virus
hematopoietic stem cell transplantation.
disease is more frequent after cord blood than
International journal of infectious diseases :
IJID : official publication of the International
Society for Infectious Diseases 19, 26-32 (2014).
blood and marrow transplantation : journal of the
American Society for Blood and Marrow
Transplantation 14, 867-871 (2008).
Seo, S. et al. Human rhinovirus detection in the
Kanda, Y. et al. Long-term low-dose acyclovir
transplant recipients: association with mortality.
against varicella-zoster virus reactivation after
Haematologica 102, 1120-1130 (2017).
allogeneic hematopoietic stem cell
https://doi.org:10.3324/haematol.2016.153767
31
Wada-Shimosato, Y. et al. Effectiveness of
689-692 (2001).
acyclovir prophylaxis against varicella zoster
https://doi.org:10.1038/sj.bmt.1703214
virus disease after allogeneic hematopoietic cell
Thomson, K. J. et al. The effect of low-dose
transplantation: A systematic review and
aciclovir on reactivation of varicella zoster virus
meta-analysis. Transplant infectious disease : an
after allogeneic haemopoietic stem cell
official journal of the Transplantation Society 21,
transplantation. Bone marrow transplantation 35,
e13061 (2019).
1065-1069 (2005).
https://doi.org:10.1111/tid.13061
32
渡辺大輔. 新規帯状疱疹サブユニットワクチン.
IASR 39, 142-144 (2018).
Boeckh, M., Kim, H. W., Flowers, M. E.,
Meyers, J. D. & Bowden, R. A. Long-term
33
Sauerbrei, A., Prager, J., Hengst, U., Zintl, F. &
acyclovir for prevention of varicella zoster virus
Wutzler, P. Varicella vaccination in children
disease after allogeneic hematopoietic cell
after bone marrow transplantation. Bone marrow
transplantation--a randomized double-blind
transplantation 20, 381-383 (1997).
placebo-controlled study. Blood 107,
https://doi.org:10.1038/sj.bmt.1700909
1800-1805 (2006).
27
30
lower respiratory tract of hematopoietic cell
https://doi.org:10.1038/sj.bmt.1704959
26
https://doi.org:10.1016/j.ijid.2013.09.020
https://doi.org:10.1016/j.bbmt.2008.05.006
transplantation. Bone marrow transplantation 28,
25
Kawamura, K. et al. Prophylactic role of
https://doi.org:10.1046/j.1365-2141.2003.044
after bone marrow transplantation. Biology of
24
Asano-Mori, Y. et al. Long-term ultra-low-dose
-9
haematology 122, 802-805 (2003).
23
28
34
Chun, J. Y. et al. Immunogenicity and safety of a
https://doi.org:10.1182/blood-2005-09-3624
live herpes zoster vaccine in hematopoietic stem
Erard, V. et al. One-year acyclovir prophylaxis
cell transplant recipients. BMC infectious
for preventing varicella-zoster virus disease
diseases 21, 117 (2021).
after hematopoietic cell transplantation: no
https://doi.org:10.1186/s12879-021-05806-4
evidence of rebound varicella-zoster virus
35
Kamboj M, Bohlke K, Baptiste DM, Dunleavy
disease after drug discontinuation. Blood 110,
K, Fueger A, Jones L et al. Vaccination of
3071-3077 (2007).
Adults With Cancer: ASCO Guideline. J Clin
https://doi.org:10.1182/blood-2007-03-07764
4
16